MARKET WIREMorningstar • 21h ago
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?Morningstar report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
Why OFIX Stock dropped -3.53% Today — RQD Quant Desk Flash
$8.75 -3.53% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $8.68
Orthofix Medical Inc. (OFIX) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • SELL / AVOID
Cap $369.4M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on OFIX Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is OFIX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Orthofix Medical Inc. (NASDAQ: OFIX) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $8.75 (-3.53% 1D, market cap $369.4M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, OFIX ranks #424 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does OFIX compare to EMBC and MOBI in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), OFIX carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of 68.8%, and ROIC of -12.2%. By comparison, EMBC (Embecta Corp.) holds a C+ grade (68/100 RQD, P/E 3.9x, ROIC 35.5%, cap $354.1M) and MOBI (Mobia Medical Inc.) posts a D grade (50/100 RQD, P/E N/A, ROIC —, cap $352.2M). Among the 5-stock peer group, EMBC leads on earnings multiple (3.9x) while EMBC leads on capital efficiency (35.5% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for OFIX?
▼
Per OFIX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884624), Orthofix Medical Inc. generated $822.3M in revenue (+2.9% YoY), -$92.2M in net income, and $33.3M in free cash flow against $850.6M in total assets and $157.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $8.68 (-0.83%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 4.1% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-7.2% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OFIX)Realized 20D OHLCV Swing Band: ±9.5%
Deterministic 5-Pillar Attribution (42/100 Composite)
🔍 WHY OFIX SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+11/20 pts (26% of score)
SEC Form 4 / 13F Thermometer: 55% Net Buy • Cannibal Buyback (-0.96% YoY Shares)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (24% of score)
Altman Z-Score 1.02 (DISTRESS RISK (<1.8)) • Piotroski F-Score 7/9
▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$9.26+6.4% Next Q
50
Q2 (-2Q)Grade D$9.85-1.4% Next Q
47
Q3 (-1Q)Grade D$9.71-9.9% Next Q
45
CurrentGrade D-$8.75-7% Hist 90D α
42
Trajectory: C- (50) → D- (42)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a OFIX Turnaround Squeeze
While OFIX currently carries a cautious 42/100 (D-) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.38) and Max Pain ($9.19) forces dealer call-delta covering toward $17.84.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.96% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $OFIX• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “OFIX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why OFIX Stock dropped -3.53% Today — RQD Quant Desk Flash
Orthofix Medical Inc. (OFIX) dropped -3.53% to $8.75, trading at 3% of its 52-week range ($8.5 – $16.99). Stretched risk/reward at current multiples (-12% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 3% of its 52-week range ($8.5 – $16.99) with RSI-14 at 44.8 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±9.5% around $8.75 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 68.8% gross margin and $33.3M annual free cash flow.
Live OFIX Headlines & Catalysts
MARKET WIRETradingView • 1d ago
Orthofix Medical Inc. Estimates – NASDAQ:OFIXTradingView report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo Finance • 1d ago
OrthoPediatrics (KIDS) Stock Sees Fair Value Lift After Higher Growth And New Product WinsYahoo Finance report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREPR Newswire • 1d ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)PR Newswire report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBusiness Wire • 1d ago
Orthofix to Report Third Quarter 2026 Financial ResultsBusiness Wire report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESimply Wall St • 1d ago
OFIX: 80% Of Spine Sales Drive The Upside, Smaller Channels Still Decide ItSimply Wall St report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Traders Daily • 1d ago
(OFIX) Movement as an Input in Quant Signal SetsStock Traders Daily report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
MARKET WIREad-hoc-news.de • 1d ago
Orthofix Medical stock sits 41.79 percent below its yearly high with USD 399.8 million valuead-hoc-news.de report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
RISK WATCHYahoo • 21d ago
Orthofix pays former executives $24M in damagesThe payments were made after a California arbitrator found private text messages between Orthofix executives couldn’t be considered cause for firing.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring OFIX)
- ✓Walkthrough of OFIX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
OFIX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -27.14%▼ DESCENDING CHANNEL
2026-11-03O $10.24H $10.24L $8.75C $8.75VOL 657.9K
RES: $10.56SUP: $8.32SMA50: $9.38SMA200: $11.05
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
OFIX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. +2.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on OFIX today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for OFIX. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for OFIX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OFIX)
Health Care Rank #424 of 1015
⚔️ EMBC vs OFIX Full Matrix →
1. Head-to-Head Health Care Peer Comparison (OFIX vs. EMBC, MOBI, SI, CLPT)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Orthofix Medical Inc. (OFIX) ranks #424 by composite RQD confidence (42/100, grade D-) and #486 by equity capitalization ($369.4M). Within this direct 5-issuer industry benchmark cohort, EMBC leads on earnings valuation at 3.9x trailing P/E, while EMBC leads on capital efficiency and profitability with 35.5% ROIC and 62.6% gross margin. EMBC currently holds the highest overall quantitative score in the immediate peer group at 68/100 (C+) compared with OFIX at 42/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| OFIX
ACTIVE
Orthofix Medical Inc. | D- | 42/100 | — | 68.8% | -12.2% | -3.53% | $369.4M | Benchmark Subject |
| EMBC Embecta Corp. | C+ | 68/100 | 3.9x | 62.6% | 35.5% | -0.96% | $354.1M | /embc-vs-ofix → |
| MOBI Mobia Medical Inc. | D | 50/100 | — | — | — | -4.82% | $352.2M | /mobi-vs-ofix → |
| SI Shoulder Innovations Inc. | D | 44/100 | — | 76.5% | -16.1% | +0.99% | $398.3M | /si-vs-ofix → |
| CLPT ClearPoint Neuro Inc. | E | 19/100 | — | 61.4% | -35.0% | -6.75% | $342.0M | /clpt-vs-ofix → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000884624 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Orthofix Medical Inc. (OFIX) reported GAAP revenue of $822.3M (+2.9% vs. FY2024 revenue of $799.5M , and +10.1% cumulative change since FY2023) , GAAP net income of -$92.2M, operating cash flow of $33.3M, and free cash flow of $33.3M (+29.3% YoY). On the balance sheet, OFIX closed FY2025 with $850.6M in total assets against $157.4M in total debt (Altman Z-Score: 1.02, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $822.3M | -$92.2M | $33.3M | $33.3M | $850.6M | $157.4M |
| FY2024 (FY) | 2024-12-31 | $799.5M | -$126.0M | $25.8M | $25.8M | $893.3M | $157.0M |
| FY2023 (FY) | 2023-12-31 | $746.6M | -$151.4M | -$45.8M | -$45.8M | — | — |
3. OFIX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs OFIX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Orthofix Medical Inc. (NASDAQ: OFIX) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $8.75 (-3.53% 1D, market cap $369.4M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, OFIX ranks #424 in composite RQD confidence.
How does OFIX compare to EMBC and MOBI in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), OFIX carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of 68.8%, and ROIC of -12.2%. By comparison, EMBC (Embecta Corp.) holds a C+ grade (68/100 RQD, P/E 3.9x, ROIC 35.5%, cap $354.1M) and MOBI (Mobia Medical Inc.) posts a D grade (50/100 RQD, P/E N/A, ROIC —, cap $352.2M). Among the 5-stock peer group, EMBC leads on earnings multiple (3.9x) while EMBC leads on capital efficiency (35.5% ROIC).
What are the biggest fundamental strengths and SEC risk factors for OFIX?
Per OFIX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884624), Orthofix Medical Inc. generated $822.3M in revenue (+2.9% YoY), -$92.2M in net income, and $33.3M in free cash flow against $850.6M in total assets and $157.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
Where is OFIX trading relative to its 50-day, 200-day, and 52-week technical levels?
OFIX last traded at $8.75 (-3.53% on volume of 565,630 shares), positioning the stock -6.72% below its 50-day simple moving average ($9.38) and -20.81% below its 200-day simple moving average ($11.05). Across its 52-week range of $8.50 to $16.99, OFIX sits at the 2.9% percentile with a 14-day RSI of 44.8 (NEUTRAL RANGE) and an implied next-earnings move of ±9.5% ($7.92 to $9.58).
ROARABLE RATING BRIEF • RQD 42/100 (D-)
✓ SEC XBRL & RQD VERIFIED
OFIX — Orthofix Medical Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Orthofix Medical Inc. (OFIX) earns a live Roarable RQD composite score of 42/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $8.75 (-3.53% 1D, market capitalization $369.4M).
- Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of -12.2%, gross margin of 68.8%, operating margin of -9.9%, and free cash flow yield of 7.99%.
- Whale 13F & Options Flow (4/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (9/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of 1.02, Piotroski F-Score of 7/9, and Debt/Equity of 0.35x.
2. Business Model, Unit Margins & SEC Financial Trajectory
Orthofix Medical Inc. (OFIX) is a NASDAQ-listed issuer in the Health Care sector, operating within the Medical/Dental Instruments industry (per the company profile). Per the market data, gross margin is 68.8%, which indicates the product mix carries high gross profitability.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Orthofix Medical Inc. (OFIX) reported $822.3M in annual revenue (up from $799.5M in FY2024, +2.9% YoY) and -$92.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($746.6M revenue, -$151.4M net income) through FY2025, OFIX scaled operating cash flow to $33.3M and free cash flow to $33.3M, backed by $850.6M in total assets against $157.4M in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D- • RQD 42/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of 7.99% and institutional whale pillar of 4/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 4/20, sustained execution supports upside toward the upper end of the $8.50 – $16.99 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh current valuation against -9.9% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream suppliers, downstream customers, and sector correlations beyond the Health Care / Medical-Dental Instruments classification are not provided.
- Key Question #1: Can OFIX sustain or expand its -9.9% operating margin and -12.2% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $822.3M and free cash flow of $33.3M, how will capital allocation balance growth reinvestment against $157.4M in total debt?
- Key Question #3: How sensitive is OFIX's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
OFIX Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Orthofix Medical Inc. (OFIX) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Morningstar • 21h ago
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? Morningstar report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Orthofix Medical Inc. Estimates – NASDAQ:OFIX TradingView report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Yahoo Finance • 1d ago
OrthoPediatrics (KIDS) Stock Sees Fair Value Lift After Higher Growth And New Product Wins Yahoo Finance report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE PR Newswire • 1d ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX) PR Newswire report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Business Wire • 1d ago
Orthofix to Report Third Quarter 2026 Financial Results Business Wire report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall St • 1d ago
OFIX: 80% Of Spine Sales Drive The Upside, Smaller Channels Still Decide It Simply Wall St report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Traders Daily • 1d ago
(OFIX) Movement as an Input in Quant Signal Sets Stock Traders Daily report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE ad-hoc-news.de • 1d ago
Orthofix Medical stock sits 41.79 percent below its yearly high with USD 399.8 million value ad-hoc-news.de report covering Orthofix Medical Inc. (OFIX) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
OFIX Bull vs. Bear Conversation Board — What's Your Call at $8.75?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OFIX 🐻 33% BEARISH CONVICTION
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH
🎯 Target: $11.25 (+24.0%)
📌 Pinned Debate Revenue rose from $746.6M to $822.3M across FY 2023–FY 2025 while the operating loss narrowed from -$139.1M to -$81.4M, and the 68.8% g
Here is why I am bullish on OFIX here at $9.07: Revenue rose from $746.6M to $822.3M across FY 2023–FY 2025 while the operating loss narrowed from -$139.1M to -$81.4M, and the 68.8% gross margin and 7.99% FCF yield are supportive.. Compare OFIX's -9.9% operating margin and -12.2% ROIC against the rest of Medical/Dental Instruments. As long as cash conversion holds up, dips toward $8.62 are getting bought.
CapAlloc_Nerd 🐂 BULL
@MultipleCompression Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Medical/Dental Instruments. If gross margin (68.8%) holds, EPS grows into the multiple faster than bears think.
MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH
🎯 Target: $6.98 (-23.0%)
Spot @ $9.07 ROIC of -12.2%, an Altman Z-Score of 1.02, and an RQD score of 47 (D) with a distribution-warning verdict point to weak fundamentals an
ROIC of -12.2%, an Altman Z-Score of 1.02, and an RQD score of 47 (D) with a distribution-warning verdict point to weak fundamentals and elevated risk.. Look at the math on OFIX: paying current EV/EBITDA multiples for -12.2% ROIC and -9.9% operating margins leaves zero margin of safety if Medical/Dental Instruments demand softens. I'd wait for a retest of $7.98 before getting long.